Iverson Begins CMS-Funded Warfarin PGx Study; Plans to Return Test Results Within 24 Hours | GenomeWeb

By Turna Ray

Iverson Genetics will attempt to avoid the pitfalls of past warfarin PGx studies by returning genetic testing results within 24 hours to doctors involved in a large trial funded by the Centers for Medicare & Medicaid Services.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.